Cargando…
Blockchain technology in the pharmaceutical industry: a systematic review
Blockchain technology is accelerating digital transformation across multiple industries, including the pharmaceutical industry. The pharmaceutical industry suffers from a lack of transparency, difficulty tracking products, lack of trust, and the shipment of expired products. Blockchain technology ha...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137953/ https://www.ncbi.nlm.nih.gov/pubmed/35634106 http://dx.doi.org/10.7717/peerj-cs.840 |
_version_ | 1784714506702684160 |
---|---|
author | Zakari, Nazik Al-Razgan, Muna Alsaadi, Amani Alshareef, Haya Al saigh, Heba Alashaikh, Lamia Alharbi, Mala Alomar, Rana Alotaibi, Seham |
author_facet | Zakari, Nazik Al-Razgan, Muna Alsaadi, Amani Alshareef, Haya Al saigh, Heba Alashaikh, Lamia Alharbi, Mala Alomar, Rana Alotaibi, Seham |
author_sort | Zakari, Nazik |
collection | PubMed |
description | Blockchain technology is accelerating digital transformation across multiple industries, including the pharmaceutical industry. The pharmaceutical industry suffers from a lack of transparency, difficulty tracking products, lack of trust, and the shipment of expired products. Blockchain technology has been applied to solve several of these problems. In this paper, we present a systematic review of the literature focusing on the adoption of blockchain technology in the pharmaceutical industry. We collected, analyzed, qualified, and discussed studies retrieved from seven databases. The initial search yielded 2,185 papers, which were screened, discussed, voted on, critically appraised, and collected by a snowball workflow that finally yielded 38 papers. The blockchain application areas covered in the papers were classified as counterfeit drug prevention, drug distribution, tracking and tracing, and safety and security. The most frequent category was counterfeit drug prevention, which is consistent with the primary objective of the pharmaceutical industry. The newer topics discussed in this study were data governance, data quality, pharmaceutical turnover, and prescription drug monitoring. We discuss issues surrounding each of these topics and research studies, along with their limitations and solutions. We also examine the challenges and future research directions of applying blockchain technology in the pharmaceutical industry. |
format | Online Article Text |
id | pubmed-9137953 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | PeerJ Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91379532022-05-28 Blockchain technology in the pharmaceutical industry: a systematic review Zakari, Nazik Al-Razgan, Muna Alsaadi, Amani Alshareef, Haya Al saigh, Heba Alashaikh, Lamia Alharbi, Mala Alomar, Rana Alotaibi, Seham PeerJ Comput Sci Agents and Multi-Agent Systems Blockchain technology is accelerating digital transformation across multiple industries, including the pharmaceutical industry. The pharmaceutical industry suffers from a lack of transparency, difficulty tracking products, lack of trust, and the shipment of expired products. Blockchain technology has been applied to solve several of these problems. In this paper, we present a systematic review of the literature focusing on the adoption of blockchain technology in the pharmaceutical industry. We collected, analyzed, qualified, and discussed studies retrieved from seven databases. The initial search yielded 2,185 papers, which were screened, discussed, voted on, critically appraised, and collected by a snowball workflow that finally yielded 38 papers. The blockchain application areas covered in the papers were classified as counterfeit drug prevention, drug distribution, tracking and tracing, and safety and security. The most frequent category was counterfeit drug prevention, which is consistent with the primary objective of the pharmaceutical industry. The newer topics discussed in this study were data governance, data quality, pharmaceutical turnover, and prescription drug monitoring. We discuss issues surrounding each of these topics and research studies, along with their limitations and solutions. We also examine the challenges and future research directions of applying blockchain technology in the pharmaceutical industry. PeerJ Inc. 2022-03-11 /pmc/articles/PMC9137953/ /pubmed/35634106 http://dx.doi.org/10.7717/peerj-cs.840 Text en ©2022 Zakari et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ Computer Science) and either DOI or URL of the article must be cited. |
spellingShingle | Agents and Multi-Agent Systems Zakari, Nazik Al-Razgan, Muna Alsaadi, Amani Alshareef, Haya Al saigh, Heba Alashaikh, Lamia Alharbi, Mala Alomar, Rana Alotaibi, Seham Blockchain technology in the pharmaceutical industry: a systematic review |
title | Blockchain technology in the pharmaceutical industry: a systematic review |
title_full | Blockchain technology in the pharmaceutical industry: a systematic review |
title_fullStr | Blockchain technology in the pharmaceutical industry: a systematic review |
title_full_unstemmed | Blockchain technology in the pharmaceutical industry: a systematic review |
title_short | Blockchain technology in the pharmaceutical industry: a systematic review |
title_sort | blockchain technology in the pharmaceutical industry: a systematic review |
topic | Agents and Multi-Agent Systems |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137953/ https://www.ncbi.nlm.nih.gov/pubmed/35634106 http://dx.doi.org/10.7717/peerj-cs.840 |
work_keys_str_mv | AT zakarinazik blockchaintechnologyinthepharmaceuticalindustryasystematicreview AT alrazganmuna blockchaintechnologyinthepharmaceuticalindustryasystematicreview AT alsaadiamani blockchaintechnologyinthepharmaceuticalindustryasystematicreview AT alshareefhaya blockchaintechnologyinthepharmaceuticalindustryasystematicreview AT alsaighheba blockchaintechnologyinthepharmaceuticalindustryasystematicreview AT alashaikhlamia blockchaintechnologyinthepharmaceuticalindustryasystematicreview AT alharbimala blockchaintechnologyinthepharmaceuticalindustryasystematicreview AT alomarrana blockchaintechnologyinthepharmaceuticalindustryasystematicreview AT alotaibiseham blockchaintechnologyinthepharmaceuticalindustryasystematicreview |